Lonza to acquire capsule manufacturer Capsugel
21 December, 2016Lonza Group has entered into a definitive agreement to acquire drug capsule manufacturer Capsugel from the latter's parent organisation, KKR.
Add-on asthma treatments now available through the PBS
20 December, 2016The Turnbull government will invest close to $130 million to give Australian asthma sufferers subsidised access to breakthrough medicines through the Pharmaceutical Benefits Scheme (PBS).
The golden touch: light-activated nanoparticles to treat macular degeneration
19 December, 2016For sufferers of age-related macular degeneration (AMD), the only way to prevent severe vision loss is to endure regular injections into the back of the eye.
Biomedical Translation Fund managers announced
13 December, 2016The Turnbull government has selected the three venture capital fund managers who will manage the Biomedical Translation Fund (BTF), intended to help take Australian biomedical discoveries out of the laboratory and to the patient.
White blood cells at the ready for chemo patients
06 December, 2016University of Queensland (UQ) researchers have developed a way to produce and administer white blood cells to cancer patients following chemotherapy.
CWE SAR-1000 small animal ventilator
06 December, 2016The SAR-1000 is CWE's ventilator for mice, rats and other small animals for in vivo research, preclinical drug development, surgery and long-duration studies.
New drug to prevent food allergies
28 November, 2016Nobel Laureate Barry Marshall is developing a drug that restores balance to the immune system to help desensitise allergic responses to foods such as peanuts and shellfish.
Clinical trial of Alzheimer's drug fails
25 November, 2016 by Lauren DavisEli Lilly regrettably announced this week that a clinical trial of its key Alzheimer's drug, solanezumab, has failed to meet the primary endpoint.
River blindness vaccine to begin trials
23 November, 2016A vaccine with the potential to prevent millions of cases of blindness is one step closer to commercialisation, with trials in cattle set to commence before the end of the year.
QuickFire Challenge winners look to solve global health issues
21 November, 2016The World Without Disease QuickFire Challenge was a global competition that sought comprehensive, end-to-end, integrated solutions that have the potential to improve the health of people around the world.
'Dimmer switch' medicines: a revolution in treatment with fewer side effects
17 November, 2016By targeting previously unappreciated drug recognition sites in the body, a new class of medicine is on the horizon that will effectively treat chronic conditions while being selective enough to eliminate side effects.
Needle-free vaccine delivery wins Young Florey Medal
10 November, 2016 by Adam FloranceProfessor Mark Kendall has been awarded the 2016 CSL Young Florey Medal for inventing a vaccine delivery system that is painless, efficient and eliminates the need for refrigeration.
Opinion: R&D tax incentives are critical to Australia's innovation economy
09 November, 2016 by Dr Cameron Ferris, Commercialisation Manager, The iQ Group GlobalThe iQ Group Global recently made a submission in response to the review of the R&D Tax Incentive released by the Minister for Industry, Innovation and Science, Greg Hunt.
Open source: the future of malaria medicines
01 November, 2016To help tackle the major health problem of malaria, a unique 'open source' study led by researchers at the University of Sydney has established a collaborative patent-free environment that is expected to accelerate the development of new malaria treatments.
Four days, three events: International BioFest 2016
27 October, 2016 by Lauren DavisToday is the last day of International BioFest — a series of three major life sciences conferences taking place over the one week.
